Co-Crystalization and In Vitro Biological Characterization of 5-Aryl-4-(5-Substituted-2-4-Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors
A potential therapeutic strategy for targeting cancer that has gained much interest is the inhibition of the ATP binding and ATPase activity of the molecular chaperone Hsp90. We have determined the structure of the human Hsp90α N-terminal domain in complex with a series of 5-aryl-4-(5-substituted-2-...
Main Authors: | Sharp, Swee Y., Roe, S. Mark, Kazlauskas, Egidijus, Čikotienė, Inga, Workman, Paul, Matulis, Daumantas, Prodromou, Chrisostomos |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439374/ |
Similar Items
-
Thermodynamics of Aryl-Dihydroxyphenyl-Thiadiazole Binding to Human Hsp90
by: Kazlauskas, Egidijus, et al.
Published: (2012) -
Correction: Thermodynamics of Aryl-Dihydroxyphenyl-Thiadiazole Binding to Human Hsp90
by: Kazlauskas, Egidijus, et al.
Published: (2012) -
Mechanisms of Hsp90 regulation
by: Prodromou, Chrisostomos
Published: (2016) -
The ‘active life’ of Hsp90 complexes☆
by: Prodromou, Chrisostomos
Published: (2012) -
2-(2,4-dihydroxyphenyl)-5-(E)-propenylbenzofuran promotes endothelial nitric oxide synthase activity in human endothelial cells
by: Ladurner, Angela, et al.
Published: (2012)